Last reviewed · How we verify

NCT03940014: PAVM

Pulmonary Arteriovenous Malformations (PAVMs) in Hereditary Haemorrhagic Telangiectasia (HHT)

Completed Last updated 7 May 2019
What this trial tests

trial testing Data collection from standard follow up in Hereditary Haemorrhagic Telangiectasia in 170 participants. Completed in 1 March 2018.

Timeline
1 January 2014
Primary endpoint
1 March 2017
1 March 2018

Quick facts

Lead sponsorHospices Civils de Lyon
StatusCompleted
Study typeOBSERVATIONAL
Enrollment170
Start date1 January 2014
Primary completion1 March 2017
Estimated completion1 March 2018

Drugs / interventions tested

Conditions studied

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Eligibility, any sex, with Hereditary Haemorrhagic Telangiectasia or Pulmonary Arteriovenous Malformation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Computed tomography (CT) is the modality of choice to characterize pulmonary arteriovenous malformations (PAVMs) in patients with hereditary haemorrhagic telangiectasia (HHT). The objective of this study was to determine if CT findings were associated with frequency of brain abscess and ischaemic stroke. This retrospective study included patients with HHT-related PAVMs. CT results, PAVM presentation (unique, multiple, disseminated or diffuse), the number of PAVMs and the largest feeding artery size, were correlated to prevalence of ischaemic stroke and brain abscess.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hereditary Haemorrhagic Telangiectasia

Currently open trials in the same condition.

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03940014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing